RESEARCH ARTICLE

Functional role of ATM in the cellular response to DNA damage

  • Ming LIU 1 ,
  • Wenxiang HU , 2
Expand
  • 1. College of Life Science, Capital Normal University, Beijing 100048, China
  • 2. Institute of Physical Organic and Medicinal Chemistry, Capital Normal University, Beijing 100048, China

Received date: 18 Jan 2010

Accepted date: 26 Jul 2010

Published date: 05 Jun 2011

Copyright

2014 Higher Education Press and Springer-Verlag Berlin Heidelberg

Abstract

Ataxia-telangiectasia mutated (ATM) plays a key role in regulating the cellular response to ionizing radiation. The tumor-suppressor gene ATM, mutations in which cause the human genetic disease ataxia telangiectasia, encodes a key protein kinase that controls the cellular response to double-stranded breaks. Activation of ATM results in phosphorylation of many downstream targets that modulate numerous damage response pathways, most notably cell cycle checkpoints. Here, we highlight some of the new developments in the field in our understanding of the mechanism of activation of ATM and its signaling pathways, explore whether DNA double-strand breaks are the sole activators of ATM and ATM-dependent signaling pathways, and address some of the prominent, unanswered questions related to ATM and its function. The scope of this article is to provide a brief overview of the recent literature on this subject and to raise questions that could be addressed in future studies.

Cite this article

Ming LIU , Wenxiang HU . Functional role of ATM in the cellular response to DNA damage[J]. Frontiers of Chemical Science and Engineering, 2011 , 5(2) : 179 -187 . DOI: 10.1007/s11705-009-0268-4

Acknowledgments

The financial support of the National Natural Science Foundation of China (Grant No. 20872095) was gratefully acknowledged.
1
Lavin M F, Shiloh Y. The genetic defect in ataxia-telangiectasia. Annual Review of Immunology, 1997, 15(1): 177–202

DOI

2
Chun H H, Gatti R A. Ataxia-telangiectasia, an evolving phenotype. DNA Repair, 2004, 3(8-9): 1187–1196

DOI

3
You Z, Bailis J M, Johnson S A, Dilworth S M, Hunter T. Rapid activation of ATM on DNA flanking double-strand breaks. Nature Cell Biology, 2007, 9(11): 1311–1318

DOI

4
Lavin M F. ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks. Oncogene, 2007, 26(56): 7749–7758

DOI

5
Li B, Liu M, Hu W X. Molecular docking and molecular dynamic simulations of fentanyl analogs binding to u-opioid receptors. Acta Phys-Chim Sin, 2010, 26(1): 206–214 (in Chinese)

6
Lovejoy C A, Cortez D. Common mechanisms of PIKK regulation. DNA Repair, 2009, 8(9): 1004–1008

DOI

7
Bonilla C Y, Melo J A, Toczyski D P. Colocalization of sensors is sufficient to activate the DNA damage checkpoint in the absence of damage. Molecular Cell, 2008, 30(3): 267–276

DOI

8
Carson C T, Schwartz R A, Stracker T H, Lilley C E, Lee D V, Weitzman M D. The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO Journal, 2003, 22(24): 6610–6620

DOI

9
Lee J H, Paull T T. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science, 2005, 308(5721): 551–554

DOI

10
Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO Journal, 2003, 22(20): 5612–5621

DOI

11
Falck J, Coates J, Jackson S P. Conserved modes of recruitment of ATM, ATR and DNA- PKcs to sites of DNA damage. Nature, 2005, 434(7033): 605–611

DOI

12
Fanning E, Klimovich V, Nager A R. A dynamic model for replication protein A (RPA) function in DNA processing pathways. Nucleic Acids Research, 2006, 34(15): 4126–4137

DOI

13
Stracker T H, Morales M, Couto S S, Hussein H, Petrini J H. The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex. Nature, 2007, 447(7141): 218–221

DOI

14
Kanu N, Behrens A. ATMIN defines an NBS1-independent pathway of ATM signalling. EMBO Journal, 2007, 26(12): 2933–2941

DOI

15
Bakkenist C J, Kastan M B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature, 2003, 421(6922): 499–506

DOI

16
Liu M, Hu W X. Applications of immunoassay in targeted drug screening. Chinese J Appl Chem, 2009, 26(Suppl): 492–496 (in Chinese)

17
Zhong X Y, Pfeifer G P, Xu X Z. Microcephalin encodes a centrosomal protein. Cell Cycle (Georgetown, Tex), 2006, 5(4): 457–458

18
Sun Y, Xu Y, Roy K, Price B D. DNA damage-induced acetylation of lysine 3016 of ATM activates ATM kinase activity. Molecular and Cellular Biology, 2007, 27(24): 8502–8509

DOI

19
Mochan T A, Venere M, DiTullio R A Jr, Halazonetis T D. 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage. Cancer Research, 2003, 63(24): 8586–8591

20
Wang B, Matsuoka S, Carpenter P B, Elledge S J. 53BP1, a mediator of the DNA damage checkpoint. Science, 2002, 298(5597): 1435–1438

DOI

21
Foray N, Marot D, Gabriel A, Randrianarison V, Carr A M, Perricaudet M, Ashworth A, Jeggo P. A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein. EMBO Journal, 2003, 22(11): 2860–2871

DOI

22
Aglipay J A, Martin S A, Tawara H, Lee S W, Ouchi T. ATM activation by ionizing radiation requires BRCA1-associated BAAT1. Journal of Biological Chemistry, 2006, 281(14): 9710–9718

DOI

23
Guo J Y, Yamada A, Kajino T, Wu J Q, Tang W, Freel C D, Feng J, Chau B N, Wang M Z, Margolis S S, Yoo H Y, Wang X F, Dunphy W G, Irusta P M, Hardwick J M, Kornbluth S. Aven-dependent activation of ATM following DNA damage. Current Biology, 2008, 18(13): 933–942

DOI

24
Kozlov S, Gueven N, Keating K, Ramsay J, Lavin M F. ATP activates ataxia-telangiectasia mutated (ATM) in Vitro: importance of autophosphorylation. Journal of Biological Chemistry, 2003, 278(11): 9309–9317

DOI

25
Berkovich E, Monnat R J Jr, Kastan M B. Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair. Nature Cell Biology, 2007, 9(6): 683–690

DOI

26
Zou L, Elledge S J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science, 2003, 300(5625): 1542–1548

DOI

27
Soutoglou E, Misteli T. Activation of the cellular DNA damage response in the absence of DNA lesions. Science, 2008, 320(5882): 1507–1510

DOI

28
Krause D R, Jonnalagadda J C, Gatei M H, Sillje H H, Zhou B B, Nigg E A, Khanna K. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1. Oncogene, 2003, 22(38): 5927–5937

DOI

29
Ziv Y, Bielopolski D, Galanty Y, Lukas C, Taya Y, Schultz D C, Lukas J, Bekker-Jensen S, Bartek J, Shiloh Y. Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway. Nature Cell Biology, 2006, 8(8): 870–876

DOI

30
Adkins M W, Tyler J K. Transcriptional activators are dispensable for transcription in the absence of Spt6-mediated chromatin reassembly of promoter regions. Molecular Cell, 2006, 21(3): 405–416

DOI

31
Cimprich K A, Cortez D. ATR: an essential regulator of genome integrity. Nature Reviews. Molecular Cell Biology, 2008, 9(8): 616–627

DOI

32
Petersen P, Chou D M, You Z S, Hunter T, Walter J C, Walter G. Protein phosphatase 2A antagonizes ATM and ATR in a Cdk2- and Cdc7-independent DNA damage checkpoint. Molecular and Cellular Biology, 2006, 26(5): 1997–2011

DOI

Outlines

/